evidenceId,evidenceType,shortDesc,desc,id,lastEdit,status,gene/entrezGeneId,gene/hugoSymbol,gene/name,gene/oncogene,gene/curatedIsoform,gene/curatedRefSeq,gene/geneAliases/0,gene/geneAliases/1,gene/geneAliases/2,gene/geneAliases/3,gene/geneAliases/4,gene/tsg,articles/0/pmid,articles/0/title,articles/0/journal,articles/0/pubDate,articles/0/volume,articles/0/issue,articles/0/pages,articles/0/authors,articles/0/elocationId,articles/0/link,articles/0/reference,articles/0/abstract,articles/1/pmid,articles/1/title,articles/1/journal,articles/1/pubDate,articles/1/volume,articles/1/issue,articles/1/pages,articles/1/authors,articles/1/elocationId,articles/1/link,articles/1/reference,articles/1/abstract,articles/2/pmid,articles/2/title,articles/2/journal,articles/2/pubDate,articles/2/volume,articles/2/issue,articles/2/pages,articles/2/authors,articles/2/elocationId,articles/2/link,articles/2/reference,articles/2/abstract,articles/3/pmid,articles/3/title,articles/3/journal,articles/3/pubDate,articles/3/volume,articles/3/issue,articles/3/pages,articles/3/authors,articles/3/elocationId,articles/3/link,articles/3/reference,articles/3/abstract,articles/4/pmid,articles/4/title,articles/4/journal,articles/4/pubDate,articles/4/volume,articles/4/issue,articles/4/pages,articles/4/authors,articles/4/elocationId,articles/4/link,articles/4/reference,articles/4/abstract,articles/5/pmid,articles/5/title,articles/5/journal,articles/5/pubDate,articles/5/volume,articles/5/issue,articles/5/pages,articles/5/authors,articles/5/elocationId,articles/5/link,articles/5/reference,articles/5/abstract,articles/6/pmid,articles/6/title,articles/6/journal,articles/6/pubDate,articles/6/volume,articles/6/issue,articles/6/pages,articles/6/authors,articles/6/elocationId,articles/6/link,articles/6/reference,articles/6/abstract
8728,GENE_BACKGROUND,,"The Mesenchymal Epithelial Transition (MET) proto-oncogene encodes the MET receptor tyrosine kinase, also called c-MET or hepatocyte growth factor (HGF) receptor. MET is a ubiquitously expressed cell surface receptor that binds to extracellular HGF, leading to the activation of several downstream intracellular pathways. These include the PI3K/AKT and RAS/RAF/MEK pathways, which promote cellular growth and proliferation, motility, migration and angiogenesis (PMID: 25770121, 23867513). Dysregulation of MET via gene amplification, germline or somatic mutations or receptor overexpression has been observed in a variety of epithelial cancers, including breast (PMID: 15455388), prostate cancer (PMID 10454259), non-small cell lung cancer (PMID: 9699182), renal papillary carcinoma (PMID: 24812413), hepatocellular (PMID: 24222167) and gastric carcinomas (PMID: 9759658).",,2017-04-26,,4233,MET,"MET proto-oncogene, receptor tyrosine kinase",True,ENST00000397752,NM_000245.2,RCCP2,HGFR,c-Met,DFNB97,AUTS9,False,25770121,Hepatocyte growth factor and Met in drug discovery.,Journal of biochemistry,2018-05-01T20:15:00,157,5,271-84,Sakai K et al,doi: 10.1093/jb/mvv027,,0001-05-01,,9699182,Differential expression of Met/hepatocyte growth factor receptor in subtypes of non-small cell lung cancers.,"Lung cancer (Amsterdam, Netherlands)",0001-04-01,20,True,2001-01-16,Tsao MS et al,,,0001-04-01,,15455388,C-Met overexpression in node-positive breast cancer identifies patients with poor clinical outcome independent of Her2/neu.,International journal of cancer,2018-02-10T20:05:00,113,4,678-82,Lengyel E et al,,,0001-02-10,,24812413,MET as a target in papillary renal cell carcinoma.,Clinical cancer research : an official journal of the American Association for Cancer Research,2018-07-01T20:14:00,20,13,3361-3,Fay AP et al,doi: 10.1158/1078-0432.CCR-14-0690,,0001-07-01,,23867513,Targeting the hepatocyte growth factor/c-Met signaling pathway in renal cell carcinoma.,"Cancer journal (Sudbury, Mass.)",2018-07-01T20:13:00,19,4,316-23,Harshman LC et al,doi: 10.1097/PPO.0b013e31829e3c9a,,0001-07-01,,24222167,A survey of c-MET expression and amplification in 287 patients with hepatocellular carcinoma.,Anticancer research,2018-11-01T20:13:00,33,11,5179-86,Lee SJ et al,,,0001-11-01,,9759658,"Amplification of c-myc, K-sam, and c-met in gastric cancers: detection by fluorescence in situ hybridization.",Laboratory investigation; a journal of technical methods and pathology,0001-09-01,78,9,1143-53,Hara T et al,,,0001-09-01,
8727,GENE_SUMMARY,,"MET, a receptor tyrosine kinase, is recurrently altered by mutation, amplification and/or overexpression in various cancers.",,2017-04-26,,4233,MET,"MET proto-oncogene, receptor tyrosine kinase",True,ENST00000397752,NM_000245.2,RCCP2,HGFR,c-Met,DFNB97,AUTS9,False,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
